Article Details

Gyroscope Therapeutics Announces Positive Interim Data from Phase I/II FOCUS Trial of ...

Retrieved on: 2021-02-12 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Gyroscope Therapeutics Announces Positive Interim Data from Phase I/II FOCUS Trial of .... View article details on hiswai:

Excerpt

Interim results showed GT005 was well tolerated and resulted in sustained increases in vitreous Complement Factor I (CFI) levels in the majority of ...

Article found on: www.citizentribune.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up